Aptalis Pharma expanding Ohio plant; Catalent partners with S. Korean company;

> Aptalis Pharma will invest $20.25 million to expand a plant in Vandalia, OH, aided by state tax incentives, and says it will create 75 jobs in 5 years. Item 

> Cleves, OH-based Tasi Group has acquired Italy's Bonfiglioli Engineering and claims now to be the largest inspection technology and leak testing company in the world serving pharmaceutical and other industries. Item 

> In a supply chain deal that extends its reach in China, U.K. drug retailer Alliance Boots has agreed to buy a 12% stake in China's Nanjing Pharmaceutical Company for about $91 million. Story

> Catalent and Seoul, South Korea-based CTC Bio, a formulation specialist, will work together to find South Korean drugs suitable for Western markets and to work with South Korean drug manufacturers to navigate the Western regulatory process. Story

And Finally... Supplement maker Body Basics is recalling one lot of ACTRA-Sx 500 Dietary Supplement Capsules after tests determined they contain the API for erectile dysfunction but that the label does not indicate that, creating a health hazard. Release

Suggested Articles

A few years ago, one of our Fierce editors met a Big Pharma R&D chief for the first time. “You’re the ones with the scary name,” he joked.

AstraZeneca has signed a $750 million deal to produce up to 300 million doses of Oxford University's COVID-19 vaccine by year's end.

Racing with some COVID-19 vaccine heavyweights, Novavax has brought on a partner to manufacture adjuvant for its in-development shot.